University at Buffalo Hematology and Medical Oncology

Topics

• Acute Myeloid Leukemia Research 351
• Multiple Myeloma Research and Treatments 330
• Lymphoma Diagnosis and Treatment 305
• CAR-T cell therapy research 283
• Cancer Immunotherapy and Biomarkers 203
• Hematopoietic Stem Cell Transplantation 158
• Renal cell carcinoma treatment 148
• Brain Metastases and Treatment 139
• Diabetes Management and Education 130
• Lung Cancer Treatments and Mutations 98
• Chronic Lymphocytic Leukemia Research 87
• Glioma Diagnosis and Treatment 86

Most cited

1. Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology

   Journal of the National Comprehensive Cancer Network : JNCCN · 2024 · 922 citations · Edwin Yau

2. Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2022 · 1,255 citations · Edwin Yau

3. Sotorasib for Lung Cancers with KRAS p.G12C Mutation.

   The New England journal of medicine · 2021 · 1,513 citations · Grace Dy

4. Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study.

   Lancet (London, England) · 2021 · 1,369 citations · Christos Fountzilas

5. Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2021 · 1,081 citations · Christos Fountzilas

6. Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.

   The New England journal of medicine · 2023 · 739 citations · Maya Khalil